-
Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates
Wednesday, February 28, 2018 - 11:08am | 835Read More...The FDA decided favorably on four of the six major PDUFA decisions due in February, with Valeant Pharmaceuticals Intl Inc (NYSE: VRX)'s Salix Pharma unit and its partner Norgine announcing an extension the PDUFA action date for Plenvu by three months to May 13, 2018, citing the time needed to...
-
Shares Of Otonomy Plunge Following Public Offering Of Stock
Wednesday, January 6, 2016 - 9:14am | 199Read More...Shares of Otonomy Inc (NASDAQ: OTIC), a clinical-stage bio-pharmaceutical company, plunged more than 5 percent in Tuesday's after-hours session after the company announced a public offering of approximately $100 million of its common stock. Otonomy stated that all shares of the common stock...
